BD Phoenix meropenem-vaborbactam panel

Tuesday, 10 April, 2018 | Supplied by: BD



BD has introduced the ability to execute in vitro rapid identification (ID) and antimicrobial susceptibility testing (AST) for meropenem-vaborbactam in its latest panel for the BD Phoenix Automated Microbiology System, which detects resistance in Enterobacteriaceae, Non-Enterobacteriaceae and most gram-positive bacteria isolates from pure culture belonging to the genera Staphylococcus, Enterococcus and Streptococcus.

The BD Phoenix offers clinical microbiology laboratories the ability to rapidly test antimicrobial resistances or susceptibilities. The company’s rapid results for ID and AST are powered through an oxidation-reduction indicator with turbidity measurement for growth detection, as well as full on-panel antimicrobial concentrations and the BDXpert system for data analysis.

Online: www.bd.com
Phone: 02 8875 7000
Related Products

Enzo Life Sciences SARS-CoV-2 IgG ELISA kit

Enzo's ELISA assay is a qualitative assay optimised to provide sensitive detection of IgG...

GeneCopoeia ACE2 and lung stable cell lines for COVID-19 research

GeneCopoeia offers collections of cell lines expressing human host factors needed for SARS-CoV-2...

Greiner Bio-One cell culture microplates

Greiner Bio-One has various microplates available, including tissue culture microplates, with a...


  • All content Copyright © 2020 Westwick-Farrow Pty Ltd